M802

M802 · Wuhan YZY Biopharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for M802, covering 2025-07-20 to 2025-07-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of M802 (HER2 and CD3) in HER2-Positive Advanced Solid Tumors [Phase 1]